Education
About Us
Working with TipRanks
Follow Us
10X Genomics (TXG)
NASDAQ:TXG
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 610.78M | $ 618.73M | $ 516.41M | $ 490.49M | $ 298.85M |
| Gross Profit | $ 414.48M | $ 409.31M | $ 396.02M | $ 416.40M | $ 240.38M |
| Operating Income | $ -194.56M | $ -265.33M | $ -167.94M | $ -52.91M | $ -85.32M |
| EBITDA | $ -133.99M | $ -205.11M | $ -128.49M | $ -24.59M | $ -513.77M |
| Net Income | $ -182.63M | $ -255.10M | $ -166.00M | $ -58.22M | $ -542.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 393.40M | $ 388.69M | $ 429.98M | $ 587.45M | $ 663.60M |
| Total Assets | $ 918.64M | $ 965.14M | $ 1.03B | $ 1.02B | $ 929.34M |
| Total Debt | $ 82.61M | $ 95.37M | $ 95.18M | $ 81.98M | $ 62.98M |
| Net Debt | $ -261.45M | $ -263.91M | $ -124.57M | $ -505.47M | $ -600.63M |
| Total Liabilities | $ 208.50M | $ 224.10M | $ 223.24M | $ 201.26M | $ 190.27M |
| Stockholders' Equity | $ 710.13M | $ 741.04M | $ 805.74M | $ 817.57M | $ 739.07M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.73M | $ -64.72M | $ -165.27M | $ -122.65M | $ -256.29M |
| Operating Cash Flow | $ 6.66M | $ -15.20M | $ -33.61M | $ -21.37M | $ -217.90M |
| Investing Cash Flow | $ -32.63M | $ 133.49M | $ -350.89M | $ -106.73M | $ -38.39M |
| Financing Cash Flow | $ 10.91M | $ 13.67M | $ 15.82M | $ 35.30M | $ 468.91M |